InsidersTradesSigma
Progressive Care Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the Progressive Care Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Progressive Care Inc. has recorded 18 public disclosures. The latest transaction was disclosed on 23 October 2023 (Attribution). Among the most active insiders: ZIEGLER JOSEPH. The full history is openly available.
18
Insider Decl.
0
Thresholds
€32,605
3 ops.
Buy Volume
·
0 ops.
Sell Volume
43Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 October 2023
Declarations18 total
15,000 shares@ US$3.1647.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-028721:0
11,111 shares@ US$4.5052.3% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-028723:0
228,240 shares@ US$2.2050.2% of flowCommon StockSEC:0001437749-23-028657:0
228,240 shares@ US$2.2050.2% of flowCommon StockSEC:0001437749-23-028658:0
8,929 shares@ US$5.6033.5% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023801:0
8,197 shares@ US$6.1034.6% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023803:0
15,000 shares@ US$3.1631.9% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023805:0
15,000 shares@ US$3.1631.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023357:0
8,929 shares@ US$5.6035.6% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023353:0
9,311 shares@ US$5.3732.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001437749-23-023359:0
228,240 shares@ US$2.2049.8% of flowCommon StockSEC:0001493152-23-023195:0
228,240 shares@ US$2.2049.8% of flowCommon StockSEC:0001493152-23-023194:0
5,000,000 shares0Common StockSEC:0001493152-22-030782:0
15,000,000 shares0Common StockSEC:0001493152-22-030723:0
5,000,000 shares0Common StockSEC:0001493152-22-030163:0
468,000 shares@ US$0.03248.5% of flowCommon StockSEC:0001213900-22-000881:0
Ideal exit: 6 Sept 2022 (T+270)
692,462 shares@ US$0.03150.0% of flowCommon StockSEC:0001213900-22-000883:0
Ideal exit: 5 Sept 2022 (T+270)
14,946 shares@ US$0.0321.5% of flowCommon StockSEC:0001213900-21-067267:0
Ideal exit: 6 Sept 2022 (T+270)
18 of 18 declarations
About Progressive Care Inc.
Progressive Care Inc. is a United States healthcare company that built its business around pharmacy services, patient support, and healthcare data/administration solutions. Founded in 2005 and incorporated in Delaware on October 31, 2006, the company developed as a niche operator focused on retail pharmacy, contract pharmacy services, and clinical support offerings. Its operational base has been in Hallandale Beach, Florida, United States. Over time, Progressive Care combined pharmacy dispensing with managed-care support functions, allowing it to address a fragmented but highly regulated corner of the healthcare market. The company’s main business lines include retail pharmacy operations, prescription fulfillment, compounded medications, 340B contract pharmacy services, medication therapy management (MTM), third-party administration and billing support, telepharmacy services, and supply arrangements for long-term care facilities. It has also offered COVID-19 diagnostics and vaccination services, along with data management and practice risk-management solutions for healthcare organizations. This mix gives the business exposure both to pharmacy economics and to administrative services that help clients manage reimbursement, compliance, and patient engagement. From a competitive standpoint, Progressive Care operates in a crowded landscape that includes large national pharmacy chains, integrated pharmacy benefit and healthcare service platforms, and specialized long-term-care pharmacy operators. Its relative positioning has been based less on scale and more on specialization, local execution, and access to niche reimbursement frameworks such as 340B. For investors, that means the equity has historically carried the characteristics of a small-cap/micro-cap healthcare name: operational leverage can be meaningful, but so can customer concentration, reimbursement pressure, and execution risk. In market terms, Progressive Care was formerly quoted on OTCQB under the symbol RXMD. A major corporate event occurred on October 1, 2024, when Progressive Care completed its merger with NextPlat Corp and became a wholly owned subsidiary of NextPlat, which is listed on NASDAQ in the United States. As a result, investors should now view Progressive Care’s healthcare operations within the broader NextPlat reporting structure rather than as a standalone public issuer. Recent developments included improved 2024 operating momentum, supported by additional 340B pharmacy service agreements and stronger prescription volumes at PharmcoRx locations. The key analytical question going forward is whether those healthcare operations can sustain growth and margin improvement inside the NextPlat platform while preserving the specialization that originally differentiated the business.
